Researchers at Harvard's Wyss Institute and clinicians at Dana-Farber Cancer Institute are working on a novel therapeutic cancer vaccine that recently entered human clinical trials.
Turning lab innovations into high-impact products
Breakthrough discoveries cannot change the world if they never leave the lab. That is why creating a rich technology pipeline is only the beginning at the Wyss Institute. Equally important is translating breakthroughs into market-ready products and devices that have high-impact applications.
We translate our most promising ideas into transformative products by developing unique partnerships and teams between faculty inventors, our expert technical staff with industrial product development experience, and an experienced in-house business development team. These teams de-risk technologies both technically and commercially to facilitate their translation into products through corporate alliances or new startups.